DAVID Fiant says his cystic fibrosis and the arduous therapy it required was so bad he "could no longer tell if I was living to heal myself or healing myself to live".
While waiting for a lung transplant, he was on oxygen therapy and had a six-hour daily care regime, as well as three to four weeks of antibiotic infusions a year.
Then he became one of the first people in France to take a new triple-drug treatment that has been hailed as a gamechanger for people with the rare life-threatening disorder.
"I took my first dose of the medicine one morning. By 3pm I was feeling first effects," he said.
For the first time in years he was able to shower by himself, climb 15 steps at once and above all "accompany my daughter to buy comic books", the 40-year-old said.
When Fiant's doctor examined him after he started the treatment, he could hear air circulating in his lungs. That had never happened before, he said.
Fiant's regime of care has since been drastically cut back -- and he has become the president of the French non-profit Vaincre la Mucoviscidose (Defeat Cystic Fibrosis).
While the treatment's results were "spectacular", he emphasised that it was no miracle.
"There is still no cure for cystic fibrosis," he stressed.
- Life expectancy rising -
More than 70,000 people worldwide are estimated to suffer from the inherited disease, in which a defective gene causes sticky mucus to build up in the lungs, digestive tract and other parts of the body.
It causes difficulty breathing as well as long-term complications such as infection which leads patients to have significantly shortened life expectancies.
However the triple-pill treatment taken by Fiant, which is sold as Kaftrio in Europe and Trikafta in the United States, has had a major impact since the US first approved it in 2019.
The life expectancy of people with cystic fibrosis born between 2017 and 2021 in the US is now 53, up from 38 a decade ago, according to US non-profit organisation the Cystic Fibrosis Foundation.
Kaftrio has been hailed as a breakthrough because it targets the underlying cause of the disease, repairing a mutated defect in the CFTR gene.
The treatment was approved by the European Union's medicines agency and by Britain in August 2020.
However, out of the 7,500 cystic fibrosis patients in France, only 40 percent are able to use the treatment.
It has not been approved for children under the age of six, and 15 percent of patients have a genetic profile that renders the treatment ineffective.
Around 900 patients who received transplants of organs such as lungs or livers are also ineligible.
- 'Sword of Damocles' -
Sabrina Perquis, 41, watched the arrival in France of the new treatment with "great hope".
But she had had a transplant 15 years ago and found out she was not able to take Kaftrio.
"It was a tough blow," she admitted.
"When you have had a transplant you live with a sword of Damocles hanging over your head because rejection is always possible," she added.
"We are asking not to be forgotten. Research must continue to find a solution for all patients."
Several research projects are at varying stages of development, searching for an answer for patients with rare genetic mutations.
Other questions remain, including whether the treatment completely blocks the disease's progress or merely slows it down, Vaincre la Mucoviscidose vice-president Pierre Foucaud said.
The number of cystic fibrosis patients who had an organ transplant fell from 21 to just two per quarter in France from 2019 to 2021, spurred by hopes that Kaftrio would render the operation unnecessary.
"But will these transplants merely be delayed by 10 to 15 years?" Foucaud asked. "We don't know."
Kaftrio has "opened up a tremendous hope for all patients" but more needs to be done, he added.
ETX Studio
Tue Sep 27 2022
More than 70,000 people worldwide are estimated to suffer from the cystic fibrosis, in which a defective gene causes sticky mucus to build up in the lungs, digestive tract and other parts of the body. - ETX Studio
Pulau Pinang, kerajaan pusat bekerjasama tarik pelaburan semikonduktor
Kerajaan Pulau Pinang akan bekerjasama dengan Kerajaan Persekutuan untuk meneruskan usaha menarik pelaburan dalam sektor semikonduktor, termasuk segmen reka bentuk litar bersepadu (IC) di negeri itu.
Rakyat Malaysia di Jordan jadi duta produk PMKS negara
Menteri Pembangunan Usahawan dan Koperasi Datuk Ewon Benedick menyarankan rakyat Malaysia yang menetap di Jordan supaya memainkan peranan sebagai “duta” untuk mempromosikan produk perusahaan mikro kecil dan sederhana (PMKS) SERTA koperasi negara.
Mohamed Khaled tiba di Indonesia, dijadual bertemu Prabowo
Menteri Pertahanan Datuk Seri Mohamed Khaled Nordin tiba di Jakarta hari ini untuk lawatan kerja rasmi sulung beliau ke Indonesia sejak memegang jawatan itu.
SPRM mohon maklumat dari Jerman
Suruhanjaya Pencegahan Rasuah Malaysia (SPRM) memohon maklumat terkini daripada pihak berkuasa Jerman mengenai dana bon 1Malaysia Development Berhad (1MDB) yang dipercayai digunakan untuk membeli kereta mewah di negara itu pada 26 Okt 2022.
SPRM siasat pemimpin kanan di utara tanah air
Seorang pemimpin kanan di utara tanah air disiasat Suruhanjaya Pencegahan Rasuah Malaysia (SPRM) kerana disyaki melantik beberapa syarikat yang mempunyai kepentingan dengannya membabitkan beberapa projek pembekalan melibatkan peruntukan kira-kira RM300,000.
Kembangkan kandungan tempatan melalui AI
Menurut Setiausaha Agung Organisasi Kerjasama Digital (DCO) Deemah Al Yahya, terdapat 2.7 peratus daripada penduduk dunia tidak berhubung malah tidak mempunyai sambungan asas internet. Beliau turut berkata infrastruktur pengkomputeran setiap negara perlu mempunyai kemampuan untuk mengembangkan kandungan tempatan khususnya yang melibatkan penggunaan AI.
AI tidak dapat ganti guru
Menteri Pendidikan Rwanda, Gaspard Twagirayezu berkata kepesatan teknologi AI dalam pendidikan tidak dapat menggantikan guru malah membantu guru dalam menyediakan bahan pengajaran yang bermanfaat kepada pelajar.
Berita tempatan pilihan sepanjang hari ini
Berikut adalah berita yang paling menjadi tumpuan sepanjang Ahad, 28 April 2024.
Mesyuarat Khas WEF: Dunia perlukan persaingan sihat dalam transisi ke Orde Baharu - Menteri Luar Arab Saudi
Menteri Luar Negeri Arab Saudi, Putera Faisal bin Farhan Al Saud berkata dunia memerlukan persaingan sihat dalam transisi daripada Orde Dunia Lama kepada Orde Baharu. Jelasnya, persaingan ini akan memberi manfaat dalam bentuk kos pengeluaran lebih rendah, perkembangan inovasi dan pelaburan lebih baik. #MesyuaratKhasWEF #WEF
Mesyuarat Khas WEF: Dunia saling tidak percaya akibat kebergantungan dipersenjatakan - Naib Presiden Suruhanjaya Eropah
Naib Presiden Suruhanjaya Eropah, Josep Borrell Fontelles berkata fenomena hilang kepercayaan yang melanda komuniti antarabangsa ketika ini adalah akibat kebergantungan yang dipersenjatakan oleh beberapa pihak. Jelasnya, situasi ini boleh membawa kepada pengasingan negara-negara tertentu dari pentas global, seterusnya menghambat pelaksanaan agenda antarabangsa. #MesyuaratKhasWEF #WEF